HemaCell
HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.
HemaCell is a company in biotechnology, pharmaceutical based in Asia-Pacific (APAC), founded in 2021.
The company sits in the biotechnology, pharmaceutical segment, where it competes on its core product or service.
The company is recorded as being based in Asia-Pacific (APAC).
The company is listed at the Debt_Financing stage of development.
Its team size is recorded as c_00001_00010 employees.
Total disclosed funding stands at about $100M.
| Sector | Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | debt_financing |
| Total funding | $100,000,000 |
Website: www.xuejibio.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account